12.21
Schlusskurs vom Vortag:
$11.17
Offen:
$11.2
24-Stunden-Volumen:
33,231
Relative Volume:
0.33
Marktkapitalisierung:
$205.22M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-4.4257
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
+4.58%
1M Leistung:
-0.33%
6M Leistung:
+32.35%
1J Leistung:
-73.09%
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OM
Outset Medical Inc
|
12.11 | 205.22M | 114.73M | -140.94M | -126.18M | -2.76 |
![]()
ABT
Abbott Laboratories
|
132.06 | 223.47B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
104.72 | 150.72B | 17.55B | 2.03B | 2.37B | 1.37 |
![]()
SYK
Stryker Corp
|
377.02 | 139.34B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
84.38 | 107.15B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.79 | 44.54B | 5.54B | 4.18B | 259.90M | 7.00 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2024-04-08 | Eingeleitet | BTIG Research | Buy |
2024-04-05 | Hochstufung | CL King | Neutral → Buy |
2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
2023-08-17 | Eingeleitet | CL King | Neutral |
2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2021-08-18 | Eingeleitet | Cowen | Outperform |
2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
2020-12-16 | Eingeleitet | Oppenheimer | Perform |
2020-10-12 | Eingeleitet | Barclays | Overweight |
2020-10-12 | Eingeleitet | BofA Securities | Buy |
2020-10-12 | Eingeleitet | Goldman | Buy |
2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical CEO sells $52,188 in stock - MSN
OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
Outset Medical Inc (OM) Trading 3.13% Higher on Apr 25 - GuruFocus
Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect? - MSN
Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 | OM Stock News - GuruFocus
Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 - The Manila Times
Outset Medical, Inc. Announces Q1 2025 Financial Results Release and Conference Call Details - Nasdaq
Outset Medical Earnings: CEO and CFO to Present Q1 2025 Results May 7 - Stock Titan
Outset Medical: The Worst Is Over, But Execution Risk Remains High (NASDAQ:OM) - Seeking Alpha
OM Token Rallies 28%, Gives Marginal Relief To Crash-Hit Holders After MANTRA Co-founder Assures 'Post-Mortem Report,' Supply Burn - Benzinga
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Outset Medical, Inc. LawsuitOM - ACCESS Newswire
Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your RightsOM - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc.(OM) Shareholders - ACCESS Newswire
Outset Medical, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your RightsOM - ACCESS Newswire
Painful week for individual investors invested in Outset Medical, Inc. (NASDAQ:OM) after 18% drop, institutions also suffered losses - Yahoo
Take Care Before Diving Into The Deep End On Outset Medical, Inc. (NASDAQ:OM) - simplywall.st
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Outset Medical LawsuitOM - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Outset Medical, Inc. Lawsuit – OM - ACCESS Newswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors with Over $300,000 Losses to Contact the Firm’s Attorneys Before Sept. 6th Deadline in Securities Fraud Class Action - ACCESS Newswire
Outset Medical stock target cut to $15 at TD Cowen By Investing.com - Investing.com Australia
Outset Medical stock target cut to $15 at TD Cowen - Investing.com
Outset Medical Inc. (OM) PT Slashed to $15 at TD Cowen Following Share Count Changes - StreetInsider
Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know - MSN
Lead Plaintiff Appointed to Represent Investors in Outset Medical Class Action - TradingView
Class Action Filed Against Outset Medical, Inc. (OM) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: - GlobeNewswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); Outset Medical, Inc. (NASDAQ: OM); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims on Your Behal - Morningstar
Outset Medical (NASDAQ:OM) Shares Down 12.7%Should You Sell? - MarketBeat
Why Did Outset Medical Inc (OM) Stock Soar 10.15%? - AInvest
Stifel raises Outset Medical stock target to $15 post-split By Investing.com - Investing.com Australia
Outset Medical Inc (OM) Shares Down 10.9% on Mar 21 - GuruFocus
Stifel raises Outset Medical stock target to $15 post-split - Investing.com India
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Outset Medical Inc-Aktie (OM) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Nash Marc | SVP Operations and R&D |
Feb 18 '25 |
Sale |
0.90 |
4,204 |
3,784 |
200,764 |
Brottem John L. | General Counsel |
Feb 18 '25 |
Sale |
0.90 |
6,145 |
5,530 |
175,043 |
Ahmed Nabeel | Chief Financial Officer |
Feb 18 '25 |
Sale |
0.90 |
8,659 |
7,793 |
250,210 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):